Fig. 23.1
Proportions of infants who did not have AD/eczema. Kaplan-Meier plots show the proportions of infants in the intervention (circle) and control (triangle) groups with AD/eczema during the first 32 weeks of life. The log-rank test indicated statistically significant differences between groups (P = 0.012)
In analyses of secondary outcomes (allergen-specific IgE concentrations), the serum levels of anti-egg white and anti-ovomucoid IgE in infants at 32 weeks were evaluated by using the diamond-like carbon [DLC] chip with high-density allergen immobilization and high sensitivity [29]. The proportions of infants who were sensitized by allergens were similar between the intervention and control groups, although the intervention group had significantly higher levels of stratum corneum hydration in the lower leg at weeks 12 and 24 compared with those seen in the control group (Fig. 23.2). A greater proportion of infants with AD/eczema had allergic sensitization based on the serum levels of anti-egg white IgE than those without AD/eczema (P = 0.043, Table 23.1).
Fig. 23.2
Stratum corneum hydration (SCH) change in the lower leg (a) and forehead (b) in each group. Symbols (circles and triangles) and bars stand for means and SDs. SCH values were significantly higher for the lower leg in the intervention group at 12 weeks of age compared with those in the control group (P < 0.05, ANOVA)
Table 23.1
Allergic sensitization at week 32
Level of specific IgE | With AD/eczema (n = 43) | Without AD/eczema (n = 49) | P values** |
---|---|---|---|
Egg white (kUA/L*) | |||
≥0.35 | 56% (24/43) | 33% (16/49) | 0.043 |
≥0.70 | 56% (24/43) | 29% (14/49) | 0.015 |
Ovomucoid (kUA/L*) | |||
>0.35 | 19% (8/43) | 8.2% (4/49) | 0.24 |
>0.70 | 12% (5/43) | 6.1% (3/49) 0.57 | 0.57 |
Loss-of-function mutations in FLG were detected in 6 of the 57 DNA samples from infants, but it was not able to demonstrate whether the development of AD/eczema correlates with the presence of mutations, probably because of the small sample size.
23.6 Soap: A Specific Issue in Japanese Bathing as a Part of Skin Care
Skin care behavior consists of a body wash and emollient application. Western guidelines of AD advice patients not to use soap for a body wash [28, 30] since the pH of soap is alkaline which neutralizes skin pH and increases protease activity on the corneo-desmosome resulting in acceleration of epidermal barrier destruction [31], and limited use of nonsoap cleansers (that are neutral to low pH, hypoallergenic, and fragrance-free) is recommended [30].
Bathing system in Japan is different from that in the other countries. Typical way of Japanese bathing is composed of a body wash with bubbling soap at outside space of bathtub, washing away all bubbled soap from the body thoroughly with plenty of warm water before bathing, and soaking the cleared body in the warm water in the bathtub (bathing). Japanese way of bathing needs plenty of water to wash a body, and soap does not usually remain on the body surface.
Therefore, many Japanese patients do not mind using soap even if its pH is alkaline, and soap does not seem to damage their skin barrier as long as it is washed away thoroughly with plenty of warm water. Although this bathing way is effective to prevent infantile seborrheic eczema, babies are susceptible to dry skin if not applied with emollient after bathing, even in high humid climate in Japan. Many participants in the Japanese RCT for the prevention of AD washed their bodies with soap.
23.7 Prevention of Food Allergy and Atopic March by Skin Care for Atopic Dermatitis
Recent epidemiological studies support that AD is one of the strong risk factors for the onset of food allergy and other allergic diseases such as bronchial asthma and allergic rhinitis [32–37]. And basic cutaneous researches have been revealing complex mechanisms of epidermal sensitization to allergens [38–42]. Treatment with proactive therapy and skin care was routinely instructed for childhood AD patients in the hospital the author have been working.
A case-control study showed that food allergen-specific IgE levels of AD patients proactively treated for 2 years significantly decreased than those of patients reactively treated [43]. An RCT carried out for prevention of hen’s egg allergy with early heated egg administration revealed that early intake of small doses of egg was effective for prevention of egg allergy but the two infants who failed to be prevented were not well controlled in their eczema [10]. Another RCT which compared proactive therapy with reactive therapy showed that proactively treated patients’ house dust mite-specific IgE remains low, while those of reactively treated patients significantly increased [44]. Post hoc analysis of the Japanese study of preventive RCT revealed that even congenitally vulnerable infants with high transepidermal water loss from birth could be protected from the onset of AD by skin care treatment with emollients carried out from first week of life [45]. A recent birth cohort study revealed that the earlier eczema emerges the higher risk of food allergy follows [46].
Those findings suggest that keeping skin clear with attentive skin care treatment might be protective against food allergy and the progression of atopic march in genetically high-risk children. In the future, large-scale intervention studies for longer period and prospective observational studies are expected to show the effectiveness of long-term skin care treatment with emollients on the onset of eczema and early intervention of eczema on prognosis of AD and other allergic diseases.
References
1.
2.
Horak F Jr, Matthews S, Ihorst G, Arshad SH, Frischer T, Kuehr J, et al. Effect of mite-impermeable mattress encasings and an educational package on the development of allergies in a multinational randomized, controlled birth-cohort study — 24 months results of the Study of Prevention of Allergy in Children in Europe. Clin Exp Allergy. 2004;34:1220. doi:10.1111/j.1365-2222.2004.02024.x.CrossrefPubMed
3.
Woodcock A, Lowe LA, Murray CS, Simpson BM, Pipis SD, Kissen P, et al. Early life environmental control: effect on symptoms, sensitization, and lung function at age 3 years. Am J Respir Crit Care Med. 2004;170:433–9. doi:10.1164/rccm.200401-083OC.CrossrefPubMed
4.
Chan-Yeung M, Ferguson A, Watson W, Dimich-Ward H, Rousseau R, Lilley M, et al. The Canadian Childhood Asthma Primary Prevention Study: outcomes at 7 years of age. J Allergy Clin Immunol. 2005;116:49–55. doi:10.1016/j.jaci.2005.03.029.CrossrefPubMed
5.
Kramer MS, Kakuma R. Cochrane Database of Systematic Reviews 2012, 9:CD000133.
6.
7.
Koplin JJ, Osborne NJ, Wake M, Martin PE, Gurrin LC, Robinson MN, et al. Can early introduction of egg prevent egg allergy in infants? A population-based study. J Allergy Clin Immunol. 2010;126:807–13. doi:10.1016/j.jaci.2010.07.028.CrossrefPubMed
8.
Du Toit G, Roberts G, Sayre PH, Bahnson HT, Radulovic S, Santos AF, et al. Randomized trial of peanut consumption in infants at risk peanut allergy. N Engl J Med. 2015;372:803–13. doi:10.1056/NEJMoa1414850.CrossrefPubMedPubMedCentral